Cover Image
Market Research Report
Product code
986456

Transcatheter Treatment: Procedures and Heart Valve Market

Published: | BCC Research | 144 Pages | Delivery time: 1-2 business days

Price

Back to Top
Transcatheter Treatment: Procedures and Heart Valve Market
Published: February 3, 2021
BCC Research
Content info: 144 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Highlights:

The global market for transcatheter treatment devices should grow from $7.1 billion in 2020 to $15.2 billion by 2025, at compound annual growth rate (CAGR) of 16.3% for the period of 2020-2025.

The U.S. market for transcatheter treatment devices should grow from $4.2 billion in 2020 to $9.0 billion by 2025, at a CAGR of 16.7% for the period of 2020-2025.

The Asia-Pacific market for transcatheter treatment devices should grow from $537.1 million in 2020 to $1.2 billion by 2025, at a CAGR of 16.9% for the period of 2020-2025.

Report Scope:

Transcatheter treatment includes procedure types such as TAVR, TAVI, TMVR and TMVI. Transcatheter procedure approaches include transfemoral, transapical and transaortic procedures. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for transcatheter treatment for heart valve diseases. The format of this study includes the following -

  • Detailed description, including demographics and cost burden, of heart valve diseases (e.g., valvular stenosis and regurgitation) and transcatheter procedure approaches (e.g., transfemoral, transapical and transaortic).
  • Detailed description and analysis of transcatheter treatments devices including TAVR, TAVI, TMVR and TMVI devices.
  • Market characterization, unmet need, market size and segmentation (by region and treatment).
  • Market drivers and restraints.
  • Detailed market projections through 2025.
  • Competition and market shares.
  • Key marketed and pipeline (R&D) products along with information about their regulatory status.
  • Strategic landscape.
  • Regulatory structure.
  • Pricing and reimbursement.
  • Observations and conclusions on the future of transcatheter treatment.
  • Profiles of market participants and associations.

Report Includes -

  • 27 data tables and 26 additional tables
  • Descriptive overview of the global market for key transcatheter treatment procedures, heart valve systems, and techniques used for the treatment of valvular diseases
  • Analyses of the global market trends, with data from 2019-2020, and projections of five-year compound annual growth rates (CAGRs) through 2025
  • Estimation of the actual market size and revenue forecast for transcatheter treatment procedures, and their corresponding market share analysis based on product type, treatment procedure and other key market segments, with major geographic regions and countries involved
  • Identification of promising new transcatheter techniques and devices still in the development and testing stages, and the probability of their successful commercialization in the next five years
  • Market forecast and market potential for transcatheter treatment procedures based on pipeline devices, on account of their estimated probability of commercial launch
  • Assessment of the impact of demographic, economic, and other factors that will drive future demand for the transcatheter treatment devices and technologies market
  • Profile description of the market leading corporations within the industry, including Abbott Laboratories, Boston Scientific Corp., Edwards Lifesciences Corp., Medtronic Inc., and St. Jude Medical Inc.
Table of Contents
Product Code: HLC204B

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Structural Heart Valve Disease

  • Disease Overview
  • Spectrum of Structural Heart Disease
  • Valvular Heart Disease
  • Symptoms and Risk Factors of Structural Heart Disease
  • Causes of Structural Heart Disease
  • Rheumatic Fever
  • Mitral Valve Prolapse
  • Peripheral Artery Disease
  • Cardiovascular Disease
  • Aortic Aneurysm
  • Obesity
  • Diagnosis of Structural Heart Disease
  • Treatment of Structural Heart Disease
  • Management Through Medication
  • Surgical Intervention: Heart Valve Repair and Replacement
  • Tobacco Smoking and Heart Disease
  • Aging, Gender and Structural Heart Diseases
  • Global Demographics
  • U.S. Demographics
  • European Demographics
  • Japanese Demographics
  • Current Challenges and Future Directions

Chapter 4 Aortic Valve Disease

  • Disease Overview
  • Types of Aortic Stenosis
  • Acquired Aortic Stenosis
  • Congenital Aortic Stenosis
  • Mild and Moderate Aortic Stenosis
  • Severe Aortic Stenosis
  • Asymptomatic Aortic Stenosis
  • Symptomatic Aortic Stenosis
  • Causes, Risk Factors and Symptoms
  • Causes
  • Symptoms
  • Risk Factors
  • Epidemiology and Economic Burden
  • Diagnosis
  • Standard Doppler Echocardiography
  • Multimodality Imaging
  • Other Techniques
  • Treatment
  • Open Surgical Treatment (SAVR)
  • Transcatheter Treatment (TAVR/TAVI)
  • Aortic Valve Repair Versus Aortic Valve Replacement
  • Types of Transcatheter Approaches
  • Open Surgical Repair (SAVR) versus Transcatheter Treatment (TAVR/TAVI)
  • TAVR and TAVI Complications
  • Key Marketed and Pipeline Products
  • Key Marketed Products
  • Key Pipeline/R&D Products
  • Unmet Need
  • Current Challenges and Future Developments

Chapter 5 Mitral Valve Disease

  • Disease Overview
  • Types of Mitral Regurgitation
  • Disease Origin
  • Disease Stage
  • Disease Symptoms
  • Causes, Risk Factors and Symptoms
  • Causes
  • Symptoms
  • Risk Factors
  • Epidemiology and Economic Burden
  • Diagnosis
  • Standard Echocardiography
  • Multimodality Imaging
  • Other Techniques
  • Treatment
  • Open Surgical Treatment (SMVR)
  • Transcatheter Treatment (TMVR and TMVI)
  • Mitral Valve Repair Versus Mitral Valve Replacement
  • Types of Transcatheter Approaches
  • Open Surgery (SMVR) Versus Transcatheter Treatment (TMVR/TMVI)
  • TMVR Complications
  • Key Marketed and Pipeline Products
  • Key Marketed Products
  • Key Pipeline/R&D Products
  • Other Less-Invasive (MIS) Mitral Valve Technologies
  • Unmet Need
  • Current Challenges and Future Developments

Chapter 6 Tricuspid Valve Disease

  • Disease Overview
  • Types of Tricuspid Regurgitation
  • Primary Tricuspid Regurgitation
  • Secondary Mitral Regurgitation
  • Causes, Risk Factors and Symptoms
  • Causes
  • Symptoms
  • Epidemiology
  • Diagnosis
  • Echocardiography and Grading
  • Other Techniques
  • Treatment
  • Medical Treatment
  • Tricuspid Valve Surgery
  • Key Marketed and Pipeline Products
  • Key Marketed Products
  • Key Pipeline/R&D Products

Chapter 7 Market Size and Growth Analysis

  • Overview
  • Market Size and Growth Analysis by Region
  • Market Size and Growth Analysis by Segment
  • Market Size and Growth Analysis by Procedure Approach
  • Market Size and Growth Analysis by Procedure (TAVR/TAVI, TMVR and TTVR)
  • Heart Valve Market: Traditional versus Transcatheter Heart Valves
  • Market Growth Drivers and Restraints
  • Market Growth Drivers
  • Market Restraints

Chapter 8 Competitive Landscape

  • Overview

Chapter 9 Company Market Strategies

  • Market Consolidation in Cardiovascular Device Market
  • Mergers and Acquisitions in the Transcatheter Treatment Device Market
  • Key Observations Regarding Transcatheter Device Industry
  • Future Strategic Landscape

Chapter 10 Regulatory Structure: Medical Devices

  • Regulatory Background
  • Regulatory Systems for Medical Devices by Region
  • U.S.
  • European Union (EU)
  • Japan

Chapter 11 Pricing and Reimbursement: Medical Devices

  • Pricing and Reimbursement Background
  • Pricing and Reimbursement for Medical Devices by Region
  • United States
  • Europe
  • Japan

Chapter 12 Conclusions: Outlook for Transcatheter Treatment Devices

  • Major Developments Influencing the Market
  • Technological Developments
  • Demographic and Economic Trends
  • Changing Structure of the Healthcare Industry
  • Long-Term Outlook for Transcatheter Treatments

Chapter 13 Company Profiles

  • ABBOTT LABORATORIES
  • BIOTRONIK
  • BOSTON SCIENTIFIC CORP.
  • BRACCO SPA
  • BRAILE BIOMEDICA
  • CARDIAC DIMENSIONS INC.
  • COLIBRI HEART VALVE LLC
  • DIRECT FLOW MEDICAL INC.
  • EDWARDS LIFESCIENCES CORP.
  • GORMAN CARDIOVASCULAR RESEARCH GROUP
  • HANSEN MEDICAL INC. (SUBSIDIARY OF AURIS HEALTH INC.)
  • HIGHLIFE SAS
  • JENAVALVE TECHNOLOGY INC.
  • MEDTRONIC INC.
  • MICRO INTERVENTIONAL DEVICES INC.
  • MICROPORT SCIENTIFIC
  • MITRASSIST LTD.
  • MVRX INC.
  • NAVIGATE CARDIAC STRUCTURES INC.
  • NEOVASC INC.
  • ST. JUDE MEDICAL INC. (SUBSIDIARY OF ABBOTT LABORATORIES)
  • VENUS MEDTECH INC.

Chapter 14 Appendix A: List of Acronyms

Chapter 15 Appendix B: Professional Organizations

  • American Heart Association
  • Center for Drug Evaluation and Research (CDER)
  • Center for Devices and Radiological Health (CDRH)
  • Centers for Medicare & Medicaid Services (CMS)
  • European Databank for Medical Devices (EUDAMED)
  • Food and Drug Administration (FDA or USFDA)
  • Hormone Foundation
  • International Diabetes Federation (IDF)
  • International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
  • Network for Excellence in Health Innovation (NEHI)
  • National Center for Biotechnology Information (NCBI)
  • National Institute of Aging (NIA)
  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • World Cancer Research Fund International
  • World Health Organization (WHO)

List of Tables

  • Summary Table : Global Market for Transcatheter Treatment Devices, by Region, Through 2025
  • Table 1 : Scope of Structural Heart Diseases
  • Table 2 : Leading Peripheral Vascular Disease Conditions
  • Table 3 : Global Prevalence of Peripheral Artery Disease, Through 2021
  • Table 4 : Global Incidence of Hypertension, by Patient Group, 2019
  • Table 5 : Global Prevalence of Angina Pectoris and Stroke, by Number of Survivors, Through 2030
  • Table 6 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
  • Table 7 : Epidemiology, AAA vs. TAA
  • Table 8 : Global vs. U.S. Prevalence of AAA, Through 2025
  • Table 9 : BMI Calculation
  • Table 10 : BMI Categories Based on Increasing Health Risks
  • Table 11 : Trends in Obesity in the World's Population, by Segment, Through 2021
  • Table 12 : U.S. Obesity and Severe Obesity vs. General Population, by Segment, Through 2021
  • Table 13 : Structural Heart Disease: Management Through Medication
  • Table 14 : Structural Heart Valve Disease Treatment Through Surgical Intervention
  • Table 15 : Estimated World Population and Annual Growth, by Age Group, Through 2030
  • Table 16 : World Population, by Region, Through 2030
  • Table 17 : U.S. Population Estimates and Projections, by Age Group, Through 2030
  • Table 18 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, Through 2020
  • Table 19 : European Population Estimates and Projections, by Age Group, Through 2030
  • Table 20 : Japanese Population Estimates and Projections, by Age Group, Through 2030
  • Table 21 : Aortic Valve Area and Calcification Score, by Stage of Aortic Stenosis
  • Table 22 : Global vs. U.S. Prevalence of Aortic Stenosis, Through 2025
  • Table 23 : Global vs. U.S. Prevalence of Severe/Symptomatic Aortic Stenosis, Through 2025
  • Table 24 : Imaging Techniques for Aortic Stenosis Diagnosis
  • Table 25 : Types of Aortic Valve and Repair Techniques
  • Table 26 : Advantages and Challenges of TAVI vs. TAVR
  • Table 27 : TAVR Access Routes for Aortic Stenosis
  • Table 28 : Key Marketed Products in Transcatheter Aortic Valve Treatment
  • Table 29 : Key Pipeline/R&D Products in Transcatheter Aortic Valve Treatment
  • Table 30 : Mitral Valve Area, by Stage of Mitral Stenosis
  • Table 31 : Global vs. U.S. Prevalence of Mitral Regurgitation, Through 2025
  • Table 32 : Global vs. U.S. Prevalence of Severe/Symptomatic Mitral Regurgitation, Through 2025
  • Table 33 : Imaging Techniques for the Diagnosis of Mitral Valve Disease
  • Table 34 : Types of Mitral Valve Repairs
  • Table 35 : Types of Mitral Valve Repairs and Techniques
  • Table 36 : TMVI vs. TMVR: Advantages and Challenges
  • Table 37 : Key Marketed Products, Transcatheter Mitral Valve Treatment
  • Table 38 : Key Pipeline/R&D Products, Transcatheter Mitral Valve Treatment
  • Table 39 : Transcatheter Mitral Valve Treatment, Other Less-Invasive (MIS) Mitral Valve Technologies
  • Table 40 : Global vs. U.S. Prevalence of Tricuspid Regurgitation, Through 2025
  • Table 41 : Imaging Techniques for the Diagnosis of Tricuspid Valve Disease
  • Table 42 : Clinical Trials for Treating Tricuspid Regurgitation Using Transcatheter Technique
  • Table 43 : Global Market for Transcatheter Treatment Devices, by Region, Through 2025
  • Table 44 : Global Market for Transcatheter Treatment Devices, by Segment, Through 2025
  • Table 45 : Global Market for Transcatheter Treatments, by Procedure (TAVR/TAVI and TMVR), Through 2025
  • Table 46 : Global Market for Heart Valves, by Type of Valve, Through 2025
  • Table 47 : Global Market for Transcatheter Treatment Devices, by Leading Company, 2019
  • Table 48 : Differences between Regulatory Approvals in the U.S. and Europe
  • Table 49 : Transcatheter Aortic Valve Procedures, Billing and Reimbursement, U.S.
  • Table 50 : Operations on Aortic Valve, ICD-10 Procedure Code
  • Table 51 : Hospital Inpatient Procedures Utilizing MS-DRGs, National Average Reimbursements, CMS
  • Table 52 : List of Acronyms

List of Figures

  • Summary Figure : Global Market for Transcatheter Treatment Devices, by Region, 2019-2025
  • Figure 1 : Global Prevalence of Peripheral Artery Disease, 2000-2021
  • Figure 2 : Global Incidence of Hypertension, by Patient Group, 2019
  • Figure 3 : Global Prevalence of Angina Pectoris and Stroke, by Number of Survivors, 2004-2030
  • Figure 4 : Global Prevalence of Congestive Heart Failure and Stroke, 2004-2030
  • Figure 5 : Global vs. U.S. Prevalence of AAA, 2019-2025
  • Figure 6 : Trends in Obesity in the World's Population, by Segment, 2012-2021
  • Figure 7 : U.S. Obesity and Severe Obesity vs. General Population, by Segment, 2016 and 2021
  • Figure 8 : Estimated World Population and Annual Growth, by Age Group, 2000-2030
  • Figure 9 : World Population, by Region, 2000-2030
  • Figure 10 : U.S. Population Estimates and Projections, by Age Group, 2000-2030
  • Figure 11 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, 2005-2020
  • Figure 12 : European Population Estimates and Projections, by Age Group, 2000-2030
  • Figure 13 : Japanese Population Estimates and Projections, by Age Group, 2000-2030
  • Figure 14 : Global vs. U.S. Prevalence of Aortic Stenosis, 2019-2025
  • Figure 15 : Global vs. U.S. Prevalence of Severe/Symptomatic Aortic Stenosis, 2019-2025
  • Figure 16 : Global vs. U.S. Prevalence of Mitral Regurgitation, 2019-2025
  • Figure 17 : Global vs. U.S. Prevalence of Severe/Symptomatic Mitral Regurgitation, 2019-2025
  • Figure 18 : Global vs. U.S. Prevalence of Tricuspid Regurgitation, 2019-2025
  • Figure 19 : Global Market for Transcatheter Treatment Devices, by Region, 2019-2025
  • Figure 20 : Global Market Shares of Transcatheter Mitral Valve Repair, by Disease Condition, 2019
  • Figure 21 : Global Market Shares of Transcatheter Treatment Devices, by Valve Type, 2019
  • Figure 22 : Global Market Shares of Transcatheter Aortic Valve Repair Market, by Procedure Approach, 2019
  • Figure 23 : Global Market for Transcatheter Treatments, by Procedure (TAVR/TAVI and TMVR), 2019-2025
  • Figure 24 : Global Market for Heart Valves, by Type of Valve, 2019-2025
  • Figure 25 : Global Heart Valve Repair Market Share, by Type of Surgery, 2019
  • Figure 26 : Global Market Shares of Transcatheter Treatment Devices, by Leading Company, 2019